BUN and/or Creatinine Increased: Intrarenal Cause
Congenital kidney anomalies
Diseases of the kidney associated with a cystic mass
Diseases of the kidney associated with a solid mass
Diseases without a mass primarily manifested as glomerular defects
Diseases without a mass in which there is primarily tubular or interstitial (tubulointerstitial) disease
Suggested Additional Lab Testing
For diseases associated with no mass that are glomerular or tubular, urinalysis is informative.
Glomerular disease is suggested by a high amount of urinary protein (including albumin) and red blood cell (RBC) casts with or without loose RBCs.
Tubular disease is suggested by a moderate degree of urinary protein that is primarily not albumin or other relatively high-molecular-weight proteins.
Granular or white blood cell (WBC) casts or loose WBCs in the urine are often associated with infection.
Because tubular dysfunction can be caused by infections and exposure to drugs, tests for infectious diseases and drug levels can be important.
Renal stones of different composition and multiple myeloma may produce tubular disease.
Tests for renal stones and multiple myeloma involve urinalysis and blood testing.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Aspirin and Colorectal Cancer
- Study Reveals Scope of Genomic Variation Within Cancer Cell Lines
- IL-23 Drives Castration-Resistant Prostate Cancer
- Religion, Spirituality, May Influence Physical Health Outcomes in Survivors of Breast Cancer
- Immediate Instillation of Mitomycin C Post-TURBT May Benefit All Patients with Bladder Cancer
- FDA Grants Accelerated Approval to Nivolumab for Small Cell Lung Cancer
- Accelerated Intensity-Modulated Radiotherapy May Improve Outcomes in Localized Lung Cancer
- FDA Grants Approval to Lenvatinib as First-Line Therapy for Hepatocellular Carcinoma
- COPD May Not Affect Survival in Patients With Small Cell Lung Cancer
- Prescription Drug Coverage in Medicare Part D Is Tied to a Survival Advantage in Myeloma